Searched for
BIOCON NEW CFO
Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...- Biocon names insider Shreehas Tambe as MD & CEO for 5 years as Siddharth Mittal steps downBiocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on March 31. He will...
- Civic woes: BJP levels 'tax chori' allegations against Congress govt in KarnatakaBengaluru's BJP has accused the state Congress government of tax theft. This follows a citizens' forum complaint to Chief Minister Siddaram...
- Sony Pictures Networks India appoints Sibaji Biswas as CFOSony Pictures Networks India (SPNI) has appointed Sibaji Biswas as their new Chief Financial Officer. Bringing over 20 years of experience,...
- Syngene International Q2 Results: Net profit drops 9% to Rs 106 croreSyngene International, the contract research and manufacturing services arm of Biocon reported a 9% year-on-year (YoY) drop in net profit t...
- Biocon Biologics names Kedar Upadhye as new CFOUpadhye will be replace current CFO MB Chinappa who will take up strategic finance role at Biocon Group and will work with Peter Bains, the...
- Biocon appoints Anupam Jindal as new CFOHe will report to the Chief Executive Officer and Managing Director Siddharth Mittal. Jindal will take over from Indranil Sen who was the i...
- Market Movers: RITES falls as OFS sails, Axis Bank gains; buy signals in 25 stocksThe BSE flagship shed 143 points to 39,745 while Nifty dipped 45 points to 11,633.
- Biocon elevates Siddharth Mittal as CEO and joint MDMittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30.
- Biocon Q2 net profit at Rs 216 croreConsolidated total income of the company stood at Rs 1,610.6 crore for the quarter under consideration.
- Siddhartha’s disappearance: India Inc honchos hit out at PE firm, I-T sleuthsSome blamed the PE investor and income-tax officers for Siddhartha’s disappearance.
- Why investors should be more worried about Lupin than DRLMain focus area remains complex generics where other cos have an advantage
- Kiran Mazumdar-Shaw gets second term as Infosys' lead independent directorMazumdar-Shaw also serves as the chairperson and managing director of biopharmaceutical company Biocon.
- Top stocks in focus on Thursday, 24 August 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Stupid study, rubbish! Mohandas Pai slams report that says 95% of Indian engineers can't codeThe study found while more than 60% candidates could not even write code that compiled, only 1.4% could write functionally correct and effi...
- Sensex, Nifty flat ahead of long weekend; top 12 stocks in focusThe S&P BSE Sensex is trading flat ahead of a long weekend. Markets will remain closed on Thursday, April 2, 2015, on account of Mahavir Ja...
- Why two ex-Infosys bosses Nilekani and Balakrishnan took the poll plungeA former CEO and a former CFO of Infosys will contest the coming general elections — Nandan Nilekani for Congress from South Bangalore, and...
- Infosys is resilient enough: Kiran Mazumdar-ShawBiocon chairman Kiran Mazumdar-Shaw was named to the board of directors of Infosys last week, the day the company saw one of its most high-...
- Panel under Adi Godrej to suggest corporate governance policyThe government today set up a Committee headed by Godrej Group chairman Adi Godrej to suggest a frame work for the "highest quality" of cor...
- Fortune's favourite: Indian women on power listICICI Bank's Chanda Kochhar, HSBC India's Naina Lal Kidwai & Biocon's Kiran Mazumdar are on the list.
Load More
